"Company launched cancer drug Lapatinib tablets in the US". This news may or may not have an impact on the stock, but the pattern and the price action clearly gives a bullish indication. Please follow strict entry and exit rules to minimize your loss as well as maximize your gains.
Entry - above 1023
Target - Trailing stop-loss
Stop-loss - below 1020
Look at the charts and make an informed decision. Thank You Happy Trading
Beware of risk involved in stock market and this is for educational purpose only.
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.